FUS-CHOP Fusion Protein Expression Coupled to p53 Deficiency Induces Liposarcoma in Mouse but Not in Human Adipose-Derived Mesenchymal Stem/Stromal Cells

Rodriguez, Rene; Rubio, Ruth; Gutierrez-Aranda, Ivan; Melen, Gustavo J.; Elosua, Carolina; García-Castro, Javier; Menendez, Pablo
February 2011
Stem Cells (Wiley-Blackwell);Feb2011, Vol. 29 Issue 2, p179
Academic Journal
Human sarcomas have been modeled in mice by expression of specific fusion genes in mesenchymal stem cells (MSCs). However, sarcoma models based on human MSCs are still missing. We attempted to develop a model of liposarcoma by expressing FUS (FUsed in Sarcoma; also termed TLS, Translocated in LipoSarcoma)-CHOP (C/EBP HOmologous Protein; also termed DDIT3, DNA Damage-Inducible Transcript 3), a hallmark mixoid liposarcoma-associated fusion oncogene, in wild-type and p53-deficient mouse and human adipose-derived mesenchymal stem/stromal cells (ASCs). FUS-CHOP induced liposarcoma-like tumors when expressed in p53 but not in wild-type (wt) mouse ASCs (mASCs). In the absence of FUS-CHOP, p53 mASCs forms leiomyosarcoma, indicating that the expression of FUS-CHOP redirects the tumor genesis/phenotype. FUS-CHOP expression in wt mASCs does not initiate sarcomagenesis, indicating that p53 deficiency is required to induce FUS-CHOP-mediated liposarcoma in fat-derived mASCs. In a human setting, p53-deficient human ASCs (hASCs) displayed a higher in vitro growth rate and a more extended lifespan than wt hASCs. However, FUS-CHOP expression did not induce further changes in culture homeostasis nor initiated liposarcoma in either wt or p53-depleted hASCs. These results indicate that FUS-CHOP expression in a p53-deficient background is sufficient to initiate liposarcoma in mouse but not in hASCs, suggesting the need of additional cooperating mutations in hASCs. A microarray gene expression profiling has shed light into the potential deregulated pathways in liposarcoma formation from p53-deficient mASCs expressing FUS-CHOP, which might also function as potential cooperating mutations in the transformation process from hASCs. S C 2011; 29:179-192


Related Articles

  • Down-Regulation of HtrA1 Activates the Epithelial- Mesenchymal Transition and ATM DNA Damage Response Pathways. Ning Wang; Eckert, Kristin A.; Zomorrodi, Ali R.; Ping Xin; Weihua Pan; Shearer, Debra A.; Weisz, Judith; Maranus, Costas D.; Clawson, Gary A. // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Expression of the serine protease HtrA1 is decreased or abrogated in a variety of human primary cancers, and higher levels of HtrA1 expression are directly related to better response to chemotherapeutics. However, the precise mechanisms leading to HtrA1 down regulation during malignant...

  • Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Robinson, Dan R; Wu, Yi-Mi; Kalyana-Sundaram, Shanker; Cao, Xuhong; Lonigro, Robert J; Sung, Yun-Shao; Chen, Chun-Liang; Zhang, Lei; Wang, Rui; Su, Fengyun; Iyer, Matthew K; Roychowdhury, Sameek; Siddiqui, Javed; Pienta, Kenneth J; Kunju, Lakshmi P; Talpaz, Moshe; Mosquera, Juan Miguel; Singer, Samuel; Schuetze, Scott M; Antonescu, Cristina R // Nature Genetics;Feb2013, Vol. 45 Issue 2, p180 

    A 44-year old woman with recurrent solitary fibrous tumor (SFT)/hemangiopericytoma was enrolled in a clinical sequencing program including whole-exome and transcriptome sequencing. A gene fusion of the transcriptional repressor NAB2 with the transcriptional activator STAT6 was detected....

  • Hyaluronan Esters Drive Smad Gene Expression and Signaling Enhancing Cardiogenesis in Mouse Embryonic and Human Mesenchymal Stem Cells. Maioli, Margherita; Santaniello, Sara; Montella, Andrea; Bandiera, Pasquale; Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Lionetti, Vincenzo; Rizzolio, Flavio; Marchesi, Irene; Bagella, Luigi; Ventura, Carlo // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: Development of molecules chemically modifying the expression of crucial orchestrator(s) of stem cell commitment may have significant biomedical impact. We have recently developed hyaluronan mixed esters of butyric and retinoic acids (HBR), turning cardiovascular stem cell fate into a...

  • Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas. Clark-Knowles, Katherine V.; Senterman, Mary K.; Collins, Olga; Vanderhyden, Barbara C. // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Epithelial ovarian cancer (EOC) is thought to arise in part from the ovarian surface epithelium (OSE); however, the molecular events underlying this transformation are poorly understood. Germline mutations in the BRCA1 tumor suppressor gene result in a significantly increased risk of developing...

  • BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. Hagenbuchner, J; Kuznetsov, A V; Obexer, P; Ausserlechner, M J // Oncogene;10/3/2013, Vol. 32 Issue 40, p4748 

    Gain of chromosome 17q correlates with high-stage disease, an adverse clinical outcome and leads to the overexpression of the antiapoptotic protein BIRC5/Survivin in neuroblastoma (NB). We have shown before that Survivin defines a threshold for the sensitivity of NB cells to DNA-damaging...

  • Nuclear deadenylation/polyadenylation factors regulate 3′ processing in response to DNA damage. Cevher, Murat A; Xiaokan Zhang; Fernandez, Sully; Sergey Kim; Baquero, Jorge; Nilsson, Per; Sean Lee; Virtanen, Anders; Kleiman, Frida E // EMBO Journal;5/19/2010, Vol. 29 Issue 10, p1674 

    We previously showed that mRNA 3′ end cleavage reaction in cell extracts is strongly but transiently inhibited under DNA-damaging conditions. The cleavage stimulation factor-50 (CstF-50) has a role in this response, providing a link between transcription-coupled RNA processing and DNA...

  • Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation. Zanier, Romina; Briot, Delphine; Dugas du Villard, Jean-Antoine; Sarasin, Alain; Rosselli, Filippo // Oncogene;6/24/2004, Vol. 23 Issue 29, p5004 

    Loss of Fanconi anemia (FA) proteins activity by recessive inherited mutations in one of the FA genes leads to a disease characterized by bone marrow failure, myeloid leukemia and DNA damage hypersensitivity. The aim of this work was to improve our understanding of the FA syndrome defining the...

  • p53 inhibits mRNA 3′ processing through its interaction with the CstF/BARD1 complex. Nazeer, F I; Devany, E; Mohammed, S; Fonseca, D; Akukwe, B; Taveras, C; Kleiman, F E // Oncogene;7/1/2011, Vol. 30 Issue 27, p3073 

    The mechanisms involved in the p53-dependent control of gene expression following DNA damage have not been completely elucidated. Here, we show that the p53 C terminus associates with factors that are required for the ultraviolet (UV)-induced inhibition of the mRNA 3′ cleavage step of the...

  • Differential Impact of Tumor Suppressor Pathways on DNA Damage Response and Therapy-Induced Transformation in a Mouse Primary Cell Model. McClendon, A. Kathleen; Dean, Jeffry L.; Ertel, Adam; Knudsen, Erik S. // PLoS ONE;2010, Vol. 5 Issue 1, p1 

    The RB and p53 tumor suppressors are mediators of DNA damage response, and compound inactivation of RB and p53 is a common occurrence in human cancers. Surprisingly, their cooperation in DNA damage signaling in relation to tumorigenesis and therapeutic response remains enigmatic. In the context...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics